The largest database of trusted experimental protocols

Temozolomide tmz

Manufactured by Merck Group
Sourced in United States, Germany, China, Italy, Macao, Ireland

Temozolomide (TMZ) is a pharmaceutical product manufactured by Merck Group. It functions as a chemotherapeutic agent used in the treatment of certain types of brain cancers. TMZ is a synthetic alkylating agent that interferes with DNA replication, leading to cell death in rapidly dividing cells.

Automatically generated - may contain errors

69 protocols using temozolomide tmz

1

Brain Cancer Chip Drug Combination Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 7 days of spheroid culture in the brain cancer chip, a combination of drugs was applied to the chip. Bevacizumab, trade name Avastin (BEV, Roche, Basel, Switzerland) was prepared at a concentration of 7.5 µM in EGM-2 media36 (link). Temozolomide (TMZ, Sigma Aldrich, St. Louis, MO) was dissolved in dimethysulfoxide (DMSO) to prepare a solution of 10 mM TMZ37 (link). This solution was further diluted to 600 µM TMZ in EGM-2 media. Cell culture media was removed from the chip and replaced by adding 7.5 µM BEV to the left inlet and 600 µM TMZ to the right inlet 100 µL at a time, repeated 4 times38 (link)–40 (link). Drug administration occurred only once, and cells were left in the brain cancer chip for 7 days following drug administration. Control (non-drug treated) brain cancer chips were maintained under the same conditions.
+ Open protocol
+ Expand
2

Functionalization of Temozolomide for Theranostics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before ligation of the pharmacologically active 4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide (temozolomide (TMZ), Sigma-Aldrich, Germany) the functionalization of TMZ with N-(2-aminopropyl)-4-(6-(pyrimidine-2-yl)-1,2,4,5-tetrazine-3-yl)benzamide (10) as a diene component was required 14 (link),24 (link),31 . 10 acts as a diene partner and the 3-mercapto-propionic-cyclohexenyl-Cy7-bis-norbornenyl-bromide-CPP 11 as a dienophilic reaction partner for the DARinvclick chemistry-mediated ligation. The resulting DARinv product 12 offers the mandatory properties of a theranostic agent.
+ Open protocol
+ Expand
3

Cytotoxicity Assay for Anticancer Drugs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in 96-well plates at 1×104 cells per well after transient transfection or adherence of stable transfected cells. After 24 h, the cells were treated with different concentrations of imatinib (Novartis, Basel, Switzerland), etoposide (VP-16) (Sigma Chemical Co., St. Louis, MO) and temozolomide (TMZ) (Sigma Chemical Co., St. Louis, MO), each at four concentrations ranging from 50 to 200 μg/ml for 48 h. The range of drug concentrations were based on earlier studies and aimed at obtaining IC50 values both for highly sensitive and resistant cases. The absorbance at 450 nm was measured after incubation with 10 μl of CCK-8 reagent (Dojindo, Molecular Technologies, Dojindo, Japan) for four hours. After shaking for one min, the spectrophotometric absorbance of the samples was determined by using Ultra Multifunctional Microplate Reader (Tecan) at 450 nm. The assay was conducted in five replicate wells for each sample and three parallel experiments were performed. For cell viability analysis, cells were plated in 96-well plates at 2×103 per well in a final volume of 100 μl. And cells were incubated with 50 μg/ml TMZ for 24, 48, 72, 96 and 120 h. Cell growth were determined with CCK-8 according to the manufacturer's instructions.
+ Open protocol
+ Expand
4

Antibody-based targeting of Sph-1P in cancer cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse antibody against ASAH1 (612302) was purchased from BD Biosciences (San Jose, CA, USA). Anti-actin, carmofur, temozolomide (TMZ), and N-oleoylethanolamine (OE), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma-Aldrich (St. Louis, MO, USA). HRP-conjugated goat anti-mouse IgG was supplied by R&D Systems, Inc. (Minneapolis, MN, USA). SDS-PAGE and western blot materials were obtained from Life Technologies, Inc. (Grand Island, NY, USA). Murine anti-Sph-1P monoclonal antibody, (LT1002) and humanized anti-Sph-1P monoclonal antibody (LT1009) were obtained from Lpath, Inc. (16 (link),17 (link)).
+ Open protocol
+ Expand
5

Preparation of TMZ, ANGPTL4, and Inhibitor Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Temozolomide (TMZ, Sigma-Aldrich, St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich) to prepare a stock solution of 100 mM. Human ANGPTL4 protein (Fc Tag) (Sino Biological, Wayne, PA, USA) was dissolved in sterile water to prepare a stock solution of 250 μg/mL. Gefitinib (Abcam, Cambridge, UK), AKT (Abcam), PI3K (Abcam), and ERK inhibitors (Abcam) were dissolved in DMSO.
+ Open protocol
+ Expand
6

Inhibiting NF-κB and Inducing Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
NF-κB inhibitor Bay 11-7082 and Temozolomide (TMZ) were purchased from Sigma-Aldrich (St. Louis, MO). Antibodies p-p65, p65, p-p50, p50, p-IκB-α, IκB-α, B-actin, Bax, Bcl-2, caspase-3, p-Src, Src, and secondary HRP-conjugated goat anti-mouse antibodies were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX). Cleaved caspase-3, Bax, p-FAK, FAK and secondary HRP-conjugated goat anti-rabbit antibodies were purchased from Cell Signalling Technology (Danvers, MA). Secondary fluorescence-conjugated goat anti-mouse and goat-rabbit antibodies were purchased from Abcam (Cambridge, MA).
+ Open protocol
+ Expand
7

CXCR4, miR-182, and PPP1R1C modulate temozolomide sensitivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
U87-MG cells were either not transfected or transfected with either of CXCR4 mimic, miR-182 mimic, or siRNA targeting PPP1R1C (Silencer Select, Life Technologies, Shanghai, China) as described above. Twelve hours after transfection, the cells were subjected to treatment with indicated concentrations of temozolomide (TMZ) (Sigma Aldrich, Shanghai, China) for 72 hours. Following treatment cell viability was measured by the MTT assay as described above.
+ Open protocol
+ Expand
8

Cytotoxicity Assay with MCL and TMZ

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCL was purchased from Sigma-Aldrich; Merck KGaA. Temozolomide (TMZ) was purchased from Sigma-Aldrich; Merck KGaA. MCL stock solution was dissolved in DMSO and stored at −20°C. Prior to use, the stock solution was diluted with DMEM medium (Gibco; Thermo Fisher Scientific, Inc.), and the final concentration of DMSO was adjusted to <0.1%. The control group was treated with carrier solvent (0.1% DMSO).
+ Open protocol
+ Expand
9

Glioma and Astrocyte Cell Cultures Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human glioma LN18, LN229, U87-MG and U251 cell lines were from American Type Culture Collection (ATCC, Manassas, VA, USA); GBM patient-derived glioma primary cultures WG4 and IPIN20160420 were generated and cultured as previously described [20 (link)] in DMEM/Nutrient Mixture F-12, GlutaMAX™ medium, supplemented with 10% FBS (Gibco Life Technologies, Rockville, MD, USA) and antibiotics. Normal human astrocytes (NHA, Lonza Walkersville, MD, USA) were cultured in a commercial medium as described [33 (link)]. Temozolomide (TMZ, Sigma-Aldrich, Munich, Germany) was dissolved in water. Olaparib (OLA, MedChemExpress, Monmouth Junction, NJ, USA) was dissolved in DMSO.
For sphere cultures, LN18 glioma cells were seeded at a low density (1500 cells/cm2) on non-adherent plates and cultured in DMEM/F-12 GlutaMAX™ supplemented with 2% B27, 20 ng/mL rhuman bFGF, 20 ng/mL rhuman EGF, 0.0002% heparin and antibiotics (for details see Supplementary Table S2). Cells were fed every 3 days by adding 1 mL of the fresh medium.
+ Open protocol
+ Expand
10

Antibody-based Assay for ASAH1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse antibody against ASAH1 (612302) was purchased from BD Biosciences (San Jose, CA). Anti-actin, carmofur, temozolomide (TMZ), and N-oleoylethanolamine (OE), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma Aldrich (St. Louis, MO). DMSO, used to dissolve carmofur, temozolomide, and OE, was purchased from Sigma Aldrich (St. Louis, MO). HRP-conjugated goat anti-mouse IgG was supplied by R&D Systems, Inc. (Minneapolis, MN). SDS-PAGE and Western blotting materials and the Annexin V kit were obtained from Life Technologies, Inc. (Grand Island, NY).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!